Medline, Inc. MDLN Acute care — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medline, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medline, Inc. 's acute care — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medline, Inc. 's acute care — net sales?
- Medline, Inc. (MDLN) reported acute care — net sales of $5.13B in Q1 2026.
- How has Medline, Inc. 's acute care — net sales changed year-over-year?
- Medline, Inc. 's acute care — net sales increased by 12.1% year-over-year, from $4.57B to $5.13B.
- What does acute care — net sales mean?
- This metric represents the total revenue generated from the sale of medical-surgical products and supply chain solutions specifically to acute care facilities, such as hospitals and surgical centers. It reflects the company's market penetration and demand within the high-acuity clinical environment, which is a primary driver of the organization's overall top-line growth. This figure excludes revenue from non-acute settings like long-term care or physician offices to isolate performance in the hospital-based segment.